Under construction – not a live service
Sign in
Taking people in DenmarkPhase 1

Phase 1 Study of MK-1084 in KRAS mutant advanced solid tumors

Key facts

Where
Odense C, DenmarkSee the site
Phase
Phase 1

Where in Denmark

  • Odense University HospitalOdense C, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Merck Sharp & Dohme LLC
Trial code
NCT05067283EU 2022-501563-40-00
Record updated
30 October 2026
Under construction, not live – Phase 1 Study of MK-1084 in KRAS mutant advanced solid tumors (NCT05067283) – Frontlight Research